Investigation of Therapeutic Effects of Erdosteine on Polycystic Ovary Syndrome in a Rat Model
Open Access
- 7 October 2018
- journal article
- research article
- Published by S. Karger AG in Medical Principles and Practice
- Vol. 27 (6) , 515-522
Abstract
Objective: Polycystic ovary syndrome (PCOS) is a serious endocrine disorder. In the present study, we investigated the therapeutic effects of erdosteine in letrozole-induced PCOS in rats. Methods: Thirty-two Wistar albino female rats were grouped as control group (C), PCOS group (PCOS), PCOS-metformin group (PCOS+MET), and PCOS-erdosteine group (PCOS+Erd). PCOS was induced by administering letrozole; such rats presented with sex hormone disorder, abnormal estrous cycles determined by daily vaginal smear, large cystic follicles, and increasing fasting insulin levels. After induction of PCOS, metformin (500 mg/kg/day) and erdosteine (100 mg/kg/day) were given orally to the treatment groups for 30 days. Serum concentrations of glucose, total cholesterol, low- and high-density lipoprotein, triglyceride, as well as the total oxidant and antioxidant status, oxidative stress index, circulating estrone (E1), estradiol (E2), testosterone, and androstenedione were evaluated. The ovaries were graded histologically. Results: Weights of ovarian tissues (p < 0.05) and the number of atretic follicles (p < 0.001) and cystic follicles (p < 0.01) decreased in the PCOS+Erd group; the corpus luteum number was significantly higher in the PCOS+Erd group (p < 0.01) as compared with the PCOS group. Lipid parameters (total-C, LDL-C, and TG), E1 (estrone), E1/E2 ratio, testosterone, and androstenedione significantly decreased, while HDL-C and E2 (estradiol) significantly increased in the PCOS+Erd group as compared with the PCOS group. Moreover glucose, insulin, and HOMA-IR were reduced with treatment of erdosteine (p > 0.05, p < 0.001, and p < 0.001, respectively). Conclusion: It is suggested that erdosteine may be used in the treatment of PCOS as an alternative to metformin. It appears that our findings might be supported by clinical and molecular studies.Keywords
This publication has 34 references indexed in Scilit:
- The effects of oxidative stress on female reproduction: a reviewReproductive Biology and Endocrinology, 2012
- Hyberbaric oxygen increases atresia in normal & steroid induced PCO rat ovariesReproductive Biology and Endocrinology, 2012
- Effects of erdosteine on cyclosporin-A-induced nephrotoxicityHuman & Experimental Toxicology, 2011
- Polycystic ovary syndrome: etiology, pathogenesis and diagnosisNature Reviews Endocrinology, 2011
- PCOS Forum: research in polycystic ovary syndrome today and tomorrowClinical Endocrinology, 2010
- Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndromeCochrane Database of Systematic Reviews, 2007
- Metformin Inhibits Proinflammatory Responses and Nuclear Factor-κB in Human Vascular Wall CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Use and Abuse of HOMA ModelingDiabetes Care, 2004
- Protective effects of erdosteine against doxorubicin‐induced cardiomyopathy in ratsJournal of Applied Toxicology, 2003
- Pathological changes related to long-term impaction of third molarsInternational Journal of Oral and Maxillofacial Surgery, 1989